Publications Browse several of our recent papers below, or to view all publications associated with the Khasraw Lab, click here. A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma (PREPRINT) 2025 KL-50: A novel therapeutic agent targeting MGMT-deficient glioblastoma 2025 A Spatial Multi-Omic Framework Identifies Gliomas Permissive to TIL Expansion (PREPRINT) 2025 IL-7-mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models 2025 A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline glioma (EDITORIAL) 2024 A brave new framework for glioma drug development 2024 Novel Immunotherapeutic Approaches for the Treatment of Glioblastoma 2023 Dendritic cell vaccine trials in gliomas: Untangling the lines 2023 Interdependencies of the Neuronal, Immune and Tumor Microenvironment in Gliomas 2023 Correcting the drug development paradigm for glioblastoma requires serial tissue sampling 2023
